Pearson’s Clinical Assessment

What Pearson’s Clinical Assessment does

Pearson's Clinical Assessment is a U.S.-headquartered operating division of Pearson plc (LSE: PSON) that develops, validates, and distributes standardized psychological, neuropsychological, educational, and clinical assessment instruments for licensed practitioners and institutions. Its portfolio spans cognition/neuro, academic learning, behavior, developmental/early childhood, motor/sensory, personality/biopsychosocial, speech/language, career planning, MTSS/RTI benchmarking, and Spanish-language assessments, available in both digital and print formats. The product architecture is built around three core delivery platforms — Q-global (web-based administration, scoring, and reporting), Q-interactive (1:1 iPad-based administration), and Q Local (desktop scoring and reporting) — with adjacent modules including aimswebPlus, Review360, Digital Assessment Libraries segmented by buyer (Healthcare, K-12, Universities), and a Telepractice platform for remote administration.

Revenue is generated through four streams: one-time assessment kit and instrument sales, recurring SaaS subscriptions on the Q-platforms, professional learning and training services (Professional Learning courses, Training Partner Program, Per-User Learning), and specialized pharma research services supporting clinical trials and neurological research. Go-to-market combines enterprise field sales to healthcare providers, school districts, universities, and government/public safety agencies with a qualifications-gated e-commerce storefront for direct professional purchases; international buyers are routed through regional offices. The division serves five principal verticals — Healthcare Providers and Clinical Practitioners (primary), K-12 Education (primary), Higher Education, Government and Public Safety, and Pharmaceutical Research — and holds approximately 38.4% North American share of the cognitive assessment market, which is forecast to grow at 8.8% CAGR through 2036. Competitive advantages rest on the depth of validated normative data, practitioner training infrastructure, and multi-channel distribution rather than on proprietary AI/ML capability, which is not evidenced in available materials.

Name

Pearson’s Clinical Assessment

Legal name

Pearson

Website

https://pearsonclinical.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Pearson's Clinical Assessment, a division of Pearson plc, develops and distributes validated psychological, neuropsychological, and educational assessment instruments via Q-global, Q-interactive, and Q Local platforms for healthcare providers, K-12 schools, universities, government agencies, and pharmaceutical researchers.

Ownership category

akta.pro rank

Product category

Clinical and Educational Assessment Software

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Diagnostic & Adaptive Assessment Content (Skills/Readiness) (EDAGADAJ)

akta.pro secondary industries

Assessment, Testing & Analytics Platforms (Formative/Summative) (EDAJAMAC), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Clinical assessment tools
• Psychological testing solutions
• Educational assessment platforms
• Cognitive evaluation software
• Telepractice assessment delivery

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

1. Assessment Tool Sales: Sale of clinical and educational assessment instruments across multiple domains including cognitive, behavioral, developmental, speech/language, and personality assessments. Products available in both digital and print formats.
2. Digital Platform Subscriptions: Recurring subscription revenue from Q-global, Q-interactive, and Q Local platforms that provide web-based and iPad-based assessment administration, scoring, and reporting services.
3. Professional Learning and Training: Training services including Professional Learning courses, Training Partner Program (TPP), and Per-User Learning offerings for practitioners seeking to enhance assessment competencies.
4. Pharma Research Services: Specialized services for pharmaceutical research including clinical trials support, providing assessment tools and expertise for drug development and neurological research.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Pearson's Clinical Assessment develops and sells psychometrically validated clinical and educational assessment instruments, delivered through its proprietary Q-global (web-based), Q-interactive (iPad-based), and Q Local (offline) platforms, covering cognitive, behavioral, developmental, academic learning, speech/language, personality/biopsychosocial, motor/sensory, career planning, and Spanish-language assessments. The offering also includes add-on solutions such as aimswebPlus, Review360, sector-specific Digital Assessment Libraries (Healthcare, K-12, Universities), Telepractice, and Professional Learning/Training services for qualified practitioners in healthcare, education, government, and pharmaceutical research.

Product overview

Pearson Clinical Assessment provides a comprehensive portfolio of professional psychological, educational, and therapy assessment tools available in both digital and print formats. The offering operates as a platform-plus-modules architecture centered around three primary digital delivery platforms: Q-global (web-based administration, scoring, and reporting), Q-interactive (iPad-based 1:1 assessment system), and Q Local (local software for scoring and reporting). These platforms serve as the infrastructure through which hundreds of specific assessments are delivered across major categories including Cognition/Neuro, Academic Learning, Behavior, Developmental/Early Childhood, Personality & Biopsychosocial, Speech & Language, Motor/Sensory, Career Planning, and MTSS/RTI/Benchmarking. Add-on solutions like aimswebPlus, Review360, and the Digital Assessment Library suites extend functionality for specific use cases. The company also offers Professional Learning and Training services including the Training Partner Program (TPP) and Per-User Training options, along with research engagement opportunities through the Research Engagement Portal. Assessment tools are available in multiple languages including Spanish, and digital solutions include Telepractice capabilities for remote administration.

Differentiator

Problem solved

Functional benefit

Brands

• Q-global: Web-based administration, scoring, and reporting platform for assessments
• Q-interactive
• Q Local
• aimswebPlus
• Review360
• Digital Assessment Library

Products and services

• Q-global Web-based platform for administration, scoring, and reporting of Pearson's professional assessments; provides cloud-based access to clinical and educational assessment tools for qualified practitioners.
• Q-interactive
• Q Local
• aimswebPlus
• Digital Assessment Library for Healthcare
• Digital Assessment Library for Schools (K-12)
• Digital Assessment Library for Universities
• Review360
• Telepractice
• Academic Learning Assessments
• Behavior Assessments
• Cognition / Neuro Assessments
• Personality & Biopsychosocial Assessments
• Speech & Language Assessments
• Developmental / Early Childhood Assessments
• Career Planning Assessments
• Motor / Sensory Assessments
• MTSS/RTI/Benchmarking Assessments
• Spanish Assessments
• Professional Learning
• Training Partner Program (TPP)
• Per-User Training
• Research Engagement Portal

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Schuhfried: European-based publisher of psychological and neuropsychological assessments (e.g., Vienna Test System). Comparable product offering but primarily serving European markets — a regional complement to Pearson's North American dominance.

Direct peers

• Riverside Insights: Provider of K-12 and clinical assessments including CogAT and Iowa Assessments. Directly competes with Pearson's K-12 portfolio (aimswebPlus, MTSS/RTI tools) and selected clinical products.
• Multi-Health Systems (MHS): Publishes validated psychological assessments including the Conners and ASRS tools. Directly competes with Pearson in clinical assessment products used by healthcare practitioners and schools.
• PAR (Psychological Assessment Resources): Direct competitor publishing clinical psychological and educational assessments used by psychologists, schools, and clinicians. Overlaps with Pearson across cognitive, behavioral, and personality assessment categories.
• Cogstate: Directly competes in computerized cognitive assessment with strong presence in clinical trials, healthcare, and research markets. Identified alongside Pearson as one of three dominant players in the global cognitive assessment market.
• Cambridge Cognition: Directly competes with Pearson in cognitive assessment, particularly for clinical trials and pharmaceutical research. Named alongside Pearson as a top-three global cognitive assessment platform provider per market commentary.
• Western Psychological Services (WPS): Publishes psychological, neuropsychological, and educational assessments with comparable digital delivery. Competes with Pearson across clinical and school-based assessment categories.

Broad incumbents

• Educational Testing Service (ETS): Large established assessment organization operating across K-12, higher education, and professional certification. While broader in scope, ETS competes with Pearson in selected K-12 and clinical/research assessment adjacencies.

Emerging players

• ImPACT Applications: Specializes in computerized cognitive testing for concussion assessment and baseline testing. Competes in an overlapping niche of computerized cognitive testing used by clinicians and public safety organizations.
• Creyos (formerly Cambridge Brain Sciences): Digital-native cognitive assessment platform focused on healthcare and research use cases. Represents the cloud-first competitive threat to Pearson's Q-global/Q-interactive stack with modern UX and lower price points.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mullen-development

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pearson’s Clinical Assessment